@article{1c70e80e693c40379f80a69906301305,
title = "Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002",
author = "Gabrielle Meyers and Mehdi Hamadani and Michael Martens and Haris Ali and Patrice Chevallier and Hannah Choe and Harris, {Andrew C.} and Ernst Holler and {van Hooren}, Eric and Willem Klaassen and Eric Leifer and {van Oosterhout}, Ypke and Lia Perez and Iskra Pusic and Matthias Stelljes and {van der Velden}, Walter and Emanuele Ammatuna and David Beauvais and J{\'e}r{\^o}me Cornillon and Maziarz, {Richard T.} and Johannes Schetelig and Jennifer Romeril and MacMillan, {Margaret L.} and Levine, {John E.} and G{\'e}rard Soci{\'e}",
note = "Funding Information: Support for this study was provided by grants U10HL069294 and U24HL138660 to the Blood and Marrow Transplant Clinical Trials Network from the National Heart, Lung, and Blood Institute and the National Cancer Institute along with contributions by Xenikos BV. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. ",
year = "2023",
month = dec,
doi = "10.1038/s41409-023-02110-4",
language = "English (US)",
volume = "58",
pages = "1416--1418",
journal = "Bone marrow transplantation",
issn = "0268-3369",
publisher = "Springer Nature",
number = "12",
}